Freestone Capital Holdings, LLC Astrazeneca PLC Transaction History

Freestone Capital Holdings, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $185,246 - $222,383	-3,126 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $174,180 - $209,817	3,126 New	3,126 $207,000
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $121,295 - $140,019	-2,572 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $26,249 - $31,388	-541 Reduced 17.38%	2,572 $129 Million
Q3 2020 Nov 06, 2020	SELL	$53.07 - $61.1 $1.83 Million - $2.1 Million	-34,433 Reduced 91.71%	3,113 $170,000
Q2 2020 Aug 04, 2020	SELL	$43.1 - $55.31 $100,595 - $129,093	-2,334 Reduced 5.85%	37,546 $1.99 Million
Q1 2020 May 12, 2020	BUY	$37.79 - $51.33 $83,251 - $113,079	2,203 Added 5.85%	39,880 $1.78 Million
Q4 2019 Feb 04, 2020	BUY	$42.46 - $50.46 $48,659 - $57,827	1,146 Added 3.14%	37,677 $1.88 Million
Q3 2019 Nov 07, 2019	BUY	$40.12 - $45.47 $170,951 - $193,747	4,261 Added 13.2%	36,531 $1.63 Million
Q2 2019 Aug 05, 2019	BUY	$37.28 - $41.68 $143,304 - $160,217	3,844 Added 13.52%	32,270 $1.33 Million
Q1 2019 May 08, 2019	BUY	$35.49 - $43.02 $436,101 - $528,629	12,288 Added 76.14%	28,426 $1.15 Million
Q4 2018 Feb 12, 2019	BUY	$36.86 - $41.49 $280,725 - $315,987	7,616 Added 89.37%	16,138 $613,000
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $296,224 - $338,493	8,522 New	8,522 $337,000

1,340

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $214B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Freestone Capital Holdings, LLC with notifications on news.